US FDA Grants Emergency Use Authorization for Antibody Treatment Administered to Trump

by Lee Seungjin

Published 22 Nov.2020 10:45(KST)

[Image source=Reuters Yonhap News]

[Asia Economy Reporter Seungjin Lee] The U.S. biotechnology company Regeneron’s antibody treatment for the novel coronavirus infection (COVID-19) has received emergency use authorization from the U.S. Food and Drug Administration (FDA).

Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

"Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
"I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
"To Get Revenge on Ex-Girlfriend" US McDonald's Manager Spits on French Fries
"How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces

According to Bloomberg and other foreign media on the 21st (local time), the FDA approved the emergency use of Regeneron’s monoclonal antibody treatment 'REGN-COV2'.

한글 기사 보기

This content was produced with the assistance of AI translation services.